Two Sigma Advisers »

Vyne Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $19k 57k 0.34

More positions owned by Two Sigma Advisers

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)
Meta Platforms Cl A (META)
Bank of America Corporation (BAC)
Mastercard Incorporated Cl A (MA)
Costco Wholesale Corporation (COST)
Lockheed Martin Corporation (LMT)
Intuitive Surgical Com New (ISRG)
Adobe Systems Incorporated (ADBE)
Charles Schwab Corporation (SCHW)

View all positions for Two Sigma Advisers

Top funds holding Vyne Therapeutics

Baker Bros. Advisors
Acorn Capital Advisors
Shay Capital
Acadian Asset Management
Ikarian Capital
Two Sigma Investments
Vanguard Group
Jane Street
Geode Capital Management
Boothbay Fund Management
Bridgeway Capital Management
Susquehanna International
Two Sigma Advisers
Corsair Capital Management
Rangeley Capital

View all funds holding Vyne Therapeutics